EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 89 filers reported holding EPIZYME INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $102,000 | +64.5% | 69,205 | +28.4% | 0.00% | – |
| Q1 2022 | $62,000 | -60.5% | 53,909 | -14.1% | 0.00% | – |
| Q4 2021 | $157,000 | -51.1% | 62,767 | 0.0% | 0.00% | – |
| Q3 2021 | $321,000 | -20.5% | 62,767 | +28.9% | 0.00% | – |
| Q2 2021 | $404,000 | -3.3% | 48,686 | +1.5% | 0.00% | – |
| Q1 2021 | $418,000 | -20.8% | 47,960 | -1.5% | 0.00% | – |
| Q4 2020 | $528,000 | -9.3% | 48,675 | -0.3% | 0.00% | – |
| Q3 2020 | $582,000 | -31.2% | 48,817 | -7.3% | 0.00% | – |
| Q2 2020 | $846,000 | +24.2% | 52,638 | +19.8% | 0.00% | – |
| Q1 2020 | $681,000 | +36.2% | 43,924 | +116.2% | 0.00% | – |
| Q4 2019 | $500,000 | +197.6% | 20,320 | +25.2% | 0.00% | – |
| Q3 2019 | $168,000 | -10.6% | 16,234 | +8.7% | 0.00% | – |
| Q2 2019 | $188,000 | +30.6% | 14,931 | +28.0% | 0.00% | – |
| Q1 2019 | $144,000 | +132.3% | 11,661 | +15.9% | 0.00% | – |
| Q4 2018 | $62,000 | -32.6% | 10,060 | +16.9% | 0.00% | – |
| Q3 2018 | $92,000 | -21.4% | 8,605 | 0.0% | 0.00% | – |
| Q2 2018 | $117,000 | -30.4% | 8,605 | -9.3% | 0.00% | – |
| Q1 2018 | $168,000 | +15.1% | 9,483 | -17.6% | 0.00% | – |
| Q4 2017 | $146,000 | -29.8% | 11,502 | +3.3% | 0.00% | – |
| Q3 2017 | $208,000 | +41.5% | 11,139 | +15.0% | 0.00% | – |
| Q2 2017 | $147,000 | -10.9% | 9,684 | 0.0% | 0.00% | – |
| Q1 2017 | $165,000 | +52.8% | 9,684 | +8.9% | 0.00% | – |
| Q4 2016 | $108,000 | +52.1% | 8,889 | +18.9% | 0.00% | – |
| Q3 2016 | $71,000 | -9.0% | 7,475 | 0.0% | 0.00% | – |
| Q2 2016 | $78,000 | -17.9% | 7,475 | 0.0% | 0.00% | – |
| Q1 2016 | $95,000 | +13.1% | 7,475 | +47.9% | 0.00% | – |
| Q4 2015 | $84,000 | +33.3% | 5,054 | 0.0% | 0.00% | – |
| Q3 2015 | $63,000 | -41.1% | 5,054 | 0.0% | 0.00% | – |
| Q2 2015 | $107,000 | +122.9% | 5,054 | +99.1% | 0.00% | – |
| Q1 2015 | $48,000 | +2.1% | 2,538 | 0.0% | 0.00% | – |
| Q4 2014 | $47,000 | -31.9% | 2,538 | 0.0% | 0.00% | – |
| Q3 2014 | $69,000 | – | 2,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |